FOXO4-DRI (Proxofim) 5mg

Description

FOXO4-DRI 5mg is the entry-level format of Nexopep’s senolytic research peptide. Proxofim works by disrupting the FOXO4-p53 interaction that protects senescent cells from apoptosis, selectively inducing cell death in senescent cells while sparing healthy ones. This 5mg format is ideal for pilot senolytic studies or dose-response investigations. Independently tested and lyophilised. For research purposes only.